RBR-3d3t8zd
Active, not recruiting
未知
Evaluation of clinical and histopathological improvement of Vulvar Lichen Sclerosus in patients with combined treatment with Topical Corticosteroids and Fractionated Microablative Radiofrequency
niversidade Federal Fluminense0 sitesJanuary 15, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversidade Federal Fluminense
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histopathological diagnosis of vulvar lichen sclerosus being treated with corticosteroids.
Exclusion Criteria
- •HIV positive women, malignant neoplasms, pregnant women, use of systemic immunosuppressants, no desire to participate in the research
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Studying the effect of addition of carboplatin and gemcitabine to standard therapy in improving response rate in breast cancer patientsBreast cancer.Malignant neoplasm of breastIRCT2017100136491N1Ministry of Research, Shiraz University of Medical Sciences, Pharmaceutical Sciences Research Center50
Recruiting
Phase 2
Ayurvedic Treatment for Oral Submucous FibrosisHealth Condition 1: D10- Benign neoplasm of mouth and pharynxCTRI/2020/02/023395Ministry of AYUSH
Recruiting
Not Applicable
Comparison of two xenografts in maxillary sinus augmentatioMaxillary sinus augmentation.Atrophy of edentulous alveolar ridgeK08.2IRCT20211122053149N1Shahid Beheshti University of Medical Sciences12
Recruiting
Not Applicable
Establishing a comprehensive tissue archive for multi-center prospective longitudinal and cohort studies - Step 1: Prostate cancer - Validation of the HistoBest Biopsy Chip(TM) (patent pending) as a diagnostic tool and enabling technology in the screening for retroviruses, genetic susceptibility and somatic mutationsACTRN12611001242910MedNewLife Medical Center100
Active, not recruiting
Phase 1
Evaluation of the combined use of Onabotulinumtoxin A and hyaluronic acid fillers in patients with facial paralysishemifacial paralysis (3 to 6 of the House-Brackmann scale)MedDRA version: 20.1Level: LLTClassification code 10016060Term: Facial palsySystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2018-004696-12-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA70